Zobrazeno 1 - 10
of 23
pro vyhledávání: '"CCB, Calcium Channel Blocker"'
Autor:
Ian Tong, Shriram Nallamshetty, Kristin Dean, James W. Thompson, Collin Berg, Prentiss Taylor, Tony Yuan
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 6, Iss 1, Pp 19-26 (2022)
Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Objectives To assess the effectiveness of telemedicine video visits in the management of hypertensive patients at home during the first year of the COVID-19 pandemic. We also evaluated associated measures of patient satisfaction with these holistic v
Autor:
Chun Liu, Karim Sallam, Pedro Medina, Nazish Sayed, Matthew V. Tran, Eric Marceau, Yu Liu, Ian Y. Chen, Matthew D. Muller, David Liang
Publikováno v:
JACC Case Reports
Coronary artery vasospasm is typically managed through avoidance of triggers and with symptomatic treatments with calcium channel blockers and long-acting nitrates. Here, we report a rare case of medically refractory coronary artery vasospasm associa
Autor:
Sarah Waliany, Ronald M. Witteles, Sandy Srinivas, Lesley S. Park, Chiyuan Amy Zhang, Kristin L. Sainani
Publikováno v:
JACC. CardioOncology, Vol 1, Iss 1, Pp 24-36 (2019)
JACC: CardioOncology
JACC: CardioOncology
Objectives This study quantified the change in blood pressure (BP) during antivascular endothelial growth factor (VEGF) tyrosine kinase inhibitor (TKI) therapy, compared BPs between TKIs, and analyzed change in BP during antihypertensive therapy. Bac
Autor:
John Moss, Charles D. Burger, Tonya Zeiger, Cher Y. Enderby, Jennifer M. Gass, Scott A Helgeson
Publikováno v:
Mayo Clinic Proceedings: Innovations, Quality & Outcomes, Vol 3, Iss 3, Pp 376-379 (2019)
Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Mayo Clinic Proceedings: Innovations, Quality & Outcomes
Pulmonary arterial hypertension is a progressive vascular disease with a high mortality rate without proper therapy. Identification of the appropriate treatment for each patient is critical in regard to adverse effects, health care costs, ease of tre
Autor:
Susumu Matsushime, Akira Kuriyama
Publikováno v:
Annals of Medicine and Surgery
Background While there are consensus recommendations for managing calcium channel blocker (CCB) toxicity, reports on angiotensin II receptor blocker (ARB) toxicity and management are limited. Herein, we report a case of catecholamine-refractory hypot
Publikováno v:
Preventive Medicine Reports, Vol 22, Iss, Pp 101344-(2021)
Preventive Medicine Reports
Preventive Medicine Reports
The Cardiovascular Health Program (CHP) Registry is a 12-month, prospective study of therapeutic lifestyle change (TLC). Adult participants received comprehensive assessment of health behaviors and cardiovascular disease (CVD) risk factors. Personali
Publikováno v:
Diabetes Research and Clinical Practice
Highlights • COVID-19 patients with poorly-controlled HbA1c showed increased worsening rate. • A HbA1c level of 8.6% (70 mmol/mol) was the optimal cutoff value. • Antidiabetic/antihypertensive drug use was not related to worsening in COVID-19 p
Autor:
Ruth Webster, Markus P. Schlaich, Peter Hay, Mark Nelson, Emily Atkins, Anthony Rodgers, Clara K Chow, Bruce Neal, Christopher M. Reid, John Chalmers, Graham S. Hillis, Anushka Patel, Laurent Billot, Tim Usherwood
Publikováno v:
American Heart Journal
High blood pressure is the leading cause of preventable morbidity and mortality globally. Many patients remain on single-drug treatment with poor control, although guidelines recognize that most require combination therapy for blood pressure control.
Autor:
Allan Johnstone, Nikolaos Brattis, Omar M. Aboumarzouk, Ameet Gupta, Gareth E. Jones, Tarik Amer, Banan Osman, Francis X. Keeley, Bhaskar K. Somani, Martin Mariappan
Publikováno v:
Arab Journal of Urology
Arab Journal of Urology, Vol 15, Iss 2, Pp 83-93 (2017)
Arab Journal of Urology, Vol 15, Iss 2, Pp 83-93 (2017)
Objective: To conduct a systematic review and meta-analysis investigating the efficacy and safety of medical expulsive therapy (MET) in low risk of bias (RoB) randomised controlled trials (RCTs). Methods: A Cochrane style systematic review was conduc
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.